Transgene Biotek has informed that it enclosed confirmation certificate dated 03rd January 2022 pursuant to Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 provided by Registrar and Share Transfer Agent ‘Bigshare Services', regarding details of shares of the Company dematerialized / rematerialized through NSDL & CDSL from 01.10.2021 to 31.12.2021.
The above information is a part of company’s filings submitted to BSE.